YP
CVS icon

Yellowstone Partners’s CVS Health CVS Stock Holding History

Yellowstone Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.53M Buy
21,178
+6,894
+48% +$501K 0.87% 27
2017
Q3 		$1.16M Buy
+14,284
New +$1.13M 0.61% 36
2016
Q3 		$935K Sell
10,511
-407
-4% -$38.4K 0.34% 79
2016
Q2 		$1.04M Sell
10,918
-864
-7% -$86.1K 0.45% 68
2016
Q1 		$1.22M Buy
11,782
+5,018
+74% +$488K 0.53% 49
2015
Q4 		$661K Buy
6,764
+3,290
+95% +$322K 0.3% 64
2015
Q3 		$335K Buy
3,474
+227
+7% +$23.9K 0.16% 117
2015
Q2 		$341K Buy
3,247
+220
+7% +$22.5K 0.15% 121
2015
Q1 		$312K Buy
3,027
+1
+0% +$101 0.16% 114
2014
Q4 		$291K Sell
3,026
-131
-4% -$11.5K 0.16% 119
2014
Q3 		$251K Buy
3,157
+238
+8% +$18.8K 0.14% 133
2014
Q2 		$220K Sell
2,919
-68
-2% -$5.14K 0.13% 146
2014
Q1 		$224K Sell
2,987
-6
-0.2% -$424 0.14% 140
2013
Q4 		$214K Buy
+2,993
New +$192K 0.14% 143

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Yellowstone Partners's CVS Position: Q4 2017 in Review

Yellowstone Partners increased its CVS Health (CVS) stake by 48% in Q4 2017, buying an estimated $501K and bringing the position to 21,178 shares worth $1.53M. The position accounts for 0.87% of the portfolio, ranked #27.

Yellowstone Partners first reported a position in CVS in Q4 2013 and has held it in 14 quarters since. 1,598 funds tracked by Wall St. Rank hold CVS as of Q4 2017.

  • Yellowstone Partners held 21,178 shares of CVS Health worth $1.53M as of Q4 2017.
  • Yellowstone Partners bought 6,894 CVS Health shares in Q4 2017, an estimated $501K.
  • CVS Health made up 0.87% of Yellowstone Partners's portfolio in Q4 2017, its #27 holding.
  • Yellowstone Partners first reported a position in CVS Health in Q4 2013 and has held it in 14 quarters since.
  • 1,598 funds tracked by Wall St. Rank held CVS Health as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.